Further establishing the effectiveness of tranilast in viral infection would support the use of TGF-β modulators for the prevention/treatment of GC insensitivity occurring during RSV infection-induced bronchiolitis or asthma/ COPD exacerbations. Here, TGFB1 is linked to chronic obstructive pulmonary disease.